The goal of this protocol is to use laser-capture micro-dissection as an effective method to isolate pure populations of cell types from heterogeneous prostate tissues for downstream RNA analysis.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
The goal of this protocol is to use laser-capture micro-dissection as an effective method to isolate pure populations of cell types from heterogeneous prostate tissues for downstream RNA analysis.
The prostate gland contains a heterogeneous milieu of stromal, epithelial, neuroendocrine and immune cell types. Healthy prostate is comprised of fibromuscular stroma surrounding discrete epithelial-lined secretory lumens and a very small population of immune and neuroendocrine cells. In contrast, areas of prostate cancer have increased dysplastic luminal epithelium with greatly reduced or absent stromal population. Given the profound difference between stromal and epithelial cell types, it is imperative to separate the cell types for any type of downstream molecular analysis. Despite this knowledge, the bulk of gene expression studies compare benign prostate to cancer without micro-dissection, leading to stromal bias in the benign samples. Laser-capture micro-dissection (LCM) is an effective method to physically separate different cell types from a specimen section. The goal of this protocol is to show that RNA can be successfully isolated from LCM-collected human prostatic epithelium and used for downstream gene expression studies such as RT-qPCR and RNAseq.
The prostate gland is a heterogeneous tissue composed of secretory epithelium arranged in glandular acini surrounded by fibromuscular stroma composed primarily of smooth muscle1. The epithelial compartment is comprised of five different but organized cell types: basal cells, secretory cells, neuroendocrine cells, transit amplifying cells and stem cells2. In prostate cancer (PCa), which arises from the luminal epithelial cells, the growth of the adenocarcinoma causes an evident progressive decline of the stromal compartment3. For these reasons, tissue specimens will have distinct differences in the proportion of stromal and epithelial c....
Access restricted. Please log in or start a trial to view this content.
All human tissues used for these experiments were acquired via an Institutional Review Board approved protocol and/or exemption at University of Illinois at Chicago.
1. Section Fresh Frozen Prostate onto PEN-slide and onto Charged Glass Slide
Access restricted. Please log in or start a trial to view this content.
In a previous study we demonstrated the use of LCM to collect epithelial and stromal tissues to compare expression profiling by RT-qPCR of mRNA and microRNAs from frozen and FFPE prostate tissues from the same patient4. LCM is time consuming, particularly if large amount of RNA is to be collected for next-generation sequencing analysis. Therefore, it is crucial to keep the working space and tools RNase free. It is recommended to examine quality and cell-specificity controls in the RNA collected (discussed in m.......
Access restricted. Please log in or start a trial to view this content.
Gene expression profiling from human specimens can be challenging, not only for the quality or quantity of tissue available, but also for the various histological entities present in a given tissue specimen. This is particularly challenging in the prostate in which benign tissues are largely stromal tissues and areas of cancer are devoid of stroma. LCM facilitates physical separation of prostatic stroma and epithelium RNA for a more accurate signature of the two different cell types (Figure 1A). In compa.......
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
We thank Dr. Vicky Macias, Angeline Giangreco and Avani Vaishnav for assistance with optimizing this methodology over the years and Yang Zhang and Dr. Jian Ma at the University of Illinois at Urbana-Champaign for the RNA seq analysis. This work was supported by NIH/NCI R01 CA166588-01 (Nonn), American Cancer Society Research Scholar 124264-RSG-13-012-01-CNE (Nonn), NIH/NCI R03 CA172827-01 (Nonn), DOD-CDMPR PRCP Health Disparities Idea Award PC121923 (Nonn) and a Prevent Cancer Foundation grant (Zhou).
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| RNase-AWAY | MBP | 7005-11 | |
| PEN-membrane 4.0 mm slides | Leica | 11600289 | |
| Glass slides, Superfrost Plus | FisherBrand | 12-550-15 | |
| Ethanol 200 proof | Decon labs. | 2701 | |
| DEPC (diethyl pyrocarbonate) | Sigma | D-5758 | |
| Cryostat | Leica | CM3050 | |
| Coplins (Staining jar) | IHCWORLD | M900-12 | |
| Coplins (Staining rack) | IHCWORLD | M905-12 | |
| Aperio ScanScope | Aperio(Leica) | ScanScope® CS | |
| Toluidine Blue | Fluka | 89640-5G | |
| Laser Microdissection System | Leica | LMD7000 | |
| 0.5 ml Thin-walled Tubes for LCM | Thermo Scientific | AB-0350 | |
| RNAqueous®-Micro Total RNA Isolation Kit | Ambion | AM1931 | Thermo Fisher Scientific Brand |
| NanoDrop | Thermo Scientific | ND-1000 | |
| Qubit 2.0 Fluorometer | Life Technologies | Q32866 | Thermo Fisher Scientific Brand |
| High-Capacity cDNA Reverse Transcription Kit | Applied Biosystems | 4368814 | Thermo Fisher Scientific Brand |
| Universal cDNA Synthesis Kit II, 8-64 rxns | Exiqon | 203301 | |
| TaqMan microRNA RT kit | Applied Biosystems | 4366597 | Thermo Fisher Scientific Brand |
| Hematoxylin stain | Ricca Chemical Company | 3536-16 | |
| Eosin-Y | Richard Allan Scientific | 7111 |
Access restricted. Please log in or start a trial to view this content.